Gene: USP43
Official Full Name: ubiquitin specific peptidase 43provided by HGNC
Gene Summary: Predicted to enable ISG15-specific peptidase activity. Predicted to be involved in translesion synthesis. Predicted to be located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27986 | USP43 Knockout cell line (HeLa) | Human | USP43 | 1:3~1:6 | Negative | Online Inquiry |
KO27987 | USP43 Knockout cell line (HCT 116) | Human | USP43 | 1:2~1:4 | Negative | Online Inquiry |
KO27988 | USP43 Knockout cell line (HEK293) | Human | USP43 | 1:3~1:6 | Negative | Online Inquiry |
KO27989 | USP43 Knockout cell line (A549) | Human | USP43 | 1:3~1:4 | Negative | Online Inquiry |
USP43 Gene Knockout Cell Lines are specifically designed cellular models that have undergone targeted genetic modifications to disrupt the expression of the USP43 gene. This gene plays a critical role in various cellular processes including protein degradation, cell cycle regulation, and responses to stress conditions, making it a significant focus for studies in cellular biology and therapeutic development.
These knockout cell lines enable researchers to investigate the physiological and pathological roles of USP43 in a precise manner. By disrupting USP43 expression, scientists can observe alterations in cellular behavior, signaling pathways, and gene expression profiles, providing insights into its involvement in diseases such as cancer, neurodegenerative disorders, and inflammation. The ability to manipulate this gene allows for advanced studies in gene function, drug response, and cellular resilience, paving the way for novel therapeutic targets.
One of the key advantages of USP43 Gene Knockout Cell Lines over existing alternatives is their superior specificity and reproducibility. These lines are generated using CRISPR/Cas9 technology, ensuring high efficiency in gene editing and minimal off-target effects. This precision mitigates the risk of artifacts commonly observed in alternative knockout strategies, resulting in more reliable and interpretable experimental outcomes.
For researchers and clinicians, the value of these cell lines lies in their utility for fundamental and translational research. The insights gained from studies leveraging USP43 knockout models could lead to significant advancements in understanding disease mechanisms and developing targeted therapies, making them indispensable tools in modern biomedical research.
At our company, we specialize in providing high-quality biological products that enhance research capabilities. Our expertise in gene editing and commitment to rigorous quality assurance ensures that our USP43 Gene Knockout Cell Lines are reliable resources for scientists dedicated to uncovering complex biological questions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.